Document is current

Article History

Accepted: 3 July 2022

First Online: 28 July 2022

Declarations

:

: The authors received no specific funding for this work.

: FSM served as an advisory board member and/or received lecture grants from AbbVie, Biogen, Galapagos, Janssen, MSD, Pfizer, Samsung Bioepis, and Takeda Pharmaceuticals. AO served as an advisory board member for AbbVie, Galapagos, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals. AO served as an advisory board member for AbbVie, MSD, Janssen, Pfizer, Takeda Pharmaceuticals, and received lecture grants from AbbVie, MSD, Sofar, Chiesi, Janssen, Pfizer, and Takeda Pharmaceuticals. SR served as an advisory board member for AbbVie, Janssen and MSD Pharmaceuticals, and received lecture grants from AbbVie, Janssen, MSD and Takeda Pharmaceuticals. FC, MG, EMB, NM, GR, AC declared no conflicting interests.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: Not applicable.

: FC and MG drafted the article. FC, MG, EMB, NM, GR, AC were responsible for critical revision of the manuscript for important intellectual content. FSM and AO were responsible for study supervision. All authors agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.